查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1197324

腹壓器械市場——增長、趨勢和預測 (2023-2028)

Intra-Abdominal Pressure Measurement Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 110 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在預測期內，腹內測壓設備市場預計將以 8.6% 左右的複合年增長率增長。

主要亮點

  • COVID-19 在早期階段對壓力表市場產生了重大影響，因為大流行限製或延遲了醫療設備的進出口和審批。 然而，自限制解除以來，該行業已經恢復良好。 腹內壓 (IAP) 設備的增加、新產品的推出和腹腔間室綜合徵的高患病率促成了過去兩年的市場復甦。
  • 推動市場增長的某些因素包括腹內高壓 (IAH) 和腹腔間隔室綜合徵 (ACS) 患病率的增加以及技術進步。 根據衛生資源服務局 (HRSA) 的 2021 年報告，2021 年美國進行了 24,670 例腎臟移植手術。 此外，等待腎移植的還有90483人。
  • 在 2022 年 2 月的一篇 PubMed 論文中，腎移植後經常觀察到 IAP 升高，並且與移植物功能延遲、術後並發症和腎功能恢復不足無關。事實證明它們是相關的。 IAP 的測量需要導尿，是一種方便且標準的方法。
  • 接受腎移植的患者需要 IAP 監測以檢測進一步的並發症，鑑於腎移植的數量，對 IAP 測量設備的需求可能會增加，從而促進市場的增長。這是一種自然現象。
  • 根據 2022 年 1 月出版的《重症監護醫學》，與非創傷中心 (NTC) 相比，在創傷中心 (TC) 中檢測到 ACS 的頻率更高。 根據同一消息來源，ACS 可能繼發於非 NTC 中的液體超載，而預計其繼發於 TC 中的休克。 此外，與 IAH 和 ACS 相關的研究活動的增加可能會在預測期內推動市場，因為它們預計會增加對 IAP 設備的需求。
  • 根據 2022 年 9 月發表在多學科數字出版研究所 (MDPI) 期刊上的一篇論文，IAH 與預後不良和手術干預需求增加相關，並伴有相關的發病率和死亡率。 發生 ACS 的創傷患者還會遭受更多的並發症、機械通氣、器官衰竭和更長的住院時間。 IAH 和 ACS 在存在緊張性腹脹的情況下發展。 IAP 升高可導致組織灌注不足，導致多器官功能障礙綜合徵並損害幾乎所有器官系統的功能。
  • IAP 監測已被證明可以顯著提高重症監護室 IAH 和/或 ACS 患者的生存率。 因此，鑑於 IAP 監測的重要性，腹內測壓設備市場在預測期內可能會增長。 鑑於 IAP 高血壓患病率上升以及 IAP 監測的重要性，腹腔內測壓設備市場在預測期內可能會增長。 然而，IPMD 在普外科的利用率很低，假陰性結果預計將在預測期內抑制市場增長。

腹腔內壓力測量裝置市場趨勢

在預測期內，醫院部門預計將佔據全球腹內壓設備市場的很大份額

  • 技術進步和住院時間延長等因素預計將在預測期內推動市場發展。 例如，2022 年 4 月在 PubMed 上發表的一篇論文將 IAH 確定為短期和長期死亡率以及嚴重器官衰竭和住院時間延長的重要且獨立的預測因子。 此外，根據 2021 年 5 月發表在 Sage Journal 上的一篇論文，IAH 與 ICU 和非 ICU 患者的急性腎臟結局相關。 因此，醫院系統通常為接受手術或慢性病治療的患者使用 IAH 測量設備，以提供更好的患者護理。 因此，它能夠在預測期內促進 IAP 測量設備細分市場的增長。
  • 隨著醫院數量的增加，對 IAH 設備的需求也將增加，從而在預測期內推動整個市場的增長。 考慮到 ICU 住院患者發生 IAP 的風險以及 IAP 測量設備的技術進步不斷增加，預計 IAP 測量設備在醫院的使用將增加，這有望在預測期內推動該細分市場的增長。
  • 例如，根據2022年AHA醫院統計，美國共有6,093家醫院，預計2022年美國所有醫院將收治33,356,853人。 因此，隨著入院人數的增加，ICU 單位對 IAP 測量設備的需求預計將增加，預計將在預測期內推動市場增長。
  • 技術進步和住院時間延長等因素預計將在預測期內推動市場發展。 例如，根據 2022 年 4 月發表在 PubMed 上的一篇論文，IAH 不僅是短期和長期死亡率的重要且獨立的預測因子，而且還可能導致器官衰竭並導致更長的住院時間。據說這就是了 此外，根據 2021 年 5 月發表在 Sage Journal 上的一篇論文，IAH 與 ICU 和非 ICU 患者的急性腎臟結局相關。 因此，醫院系統通常為接受手術或慢性病治療的患者使用 IAH 測量設備，以提供更好的患者護理。 因此，它能夠在預測期內促進 IAP 測量設備細分市場的增長。
  • 隨著醫院數量的增加，對 IAH 測量設備的需求也會增加，這可能會在預測期內推動整個市場的增長。 此外，根據美國醫院協會（AHA）2022年醫院統計，美國共有6093家醫院，預計2022年美國所有醫院的住院總人數為33356853人。 因此，隨著入院人數的增加，ICU 單位可能需要 IAP 測量設備，這有望在預測期內推動 IAP 測量設備的市場增長。
  • 此外，根據美國癌症協會 (ACS) 2022 年的一份報告，腎癌是男性和女性最常見的 10 種癌症之一。 該報告估計，到 2022 年，女性腎癌病例可能達到 28,710 例，男性病例可能達到 50,290 例。 總體而言，男性一生中患腎癌的風險約為四分之一 (2.02%)。 對於女性，終生風險約為八分之一 (1.03%)。 因此，IAH 很可能發生在患有高危腎病的人群中，預計會導致住院治療，這將在預測期內推動 IAP 測量設備市場的增長。
  • 鑑於 ICU 住院患者發生 IAP 的風險和 IAP 測量設備的技術進步，預計 IAP 測量設備在醫院的使用將會增加，從而在預測期內推動該細分市場的增長。

北美預計在預測期內見證腹內測壓設備市場的增長

  • 在北美，由於醫院和門診手術中心的快速增加、先進醫療技術的引入、慢性病患者數量的增加以及腹內高壓的流行。
  • 腹腔內高壓 (IAH) 和腹腔間隔室綜合徵 (ACS) 是重症監護病房 (ICU) 患者可能會遇到的兩種並發症。 ACS 和 IAH 影響所有身體系統，尤其是心血管、呼吸、腎臟和神經系統。 因此，北美地區越來越多的慢性病可能會為 IAP 設備市場創造需求。 例如，國際癌症研究機構 (IARC) 估計，到 2040 年，加拿大將有 10,030 人患有腎癌。
  • 目前，數字 IAP 監測器常用於 ICU 中，用於對不需要醫生監督的患者進行持續監測。 因此，IAP 監測設備的數字化將推進 IAP 儀表市場。 例如，在2022年6月發表在OTA雜誌上的一個案例中，介紹了MY01（NXTSENS，加拿大蒙特利爾）是一種微創設備，可以準確、連續地測量室內壓力的變化。
  • 無法進行連續臨床監測的 1 級創傷設施和農村地區的 ACS 管理將在很大程度上受到初步臨床數據的影響。 最後，ICP 連續監測有可能成為外傷科醫生和外傷患者的寶貴工具。 同樣，數字壓力監測器等創新設備的可用性和使用預計在不久的將來會增加對筋膜室綜合症測量設備的需求。
  • 由於醫院和門診手術中心的增加、先進醫療技術的採用、腹內高壓的高患病率等，預計在預測期內北美的 IAP 測量設備市場將出現增長。

腹部壓力計市場競爭者分析

IAP 測量設備市場競爭激烈，由幾家主要參與者組成。 公司正在採用合併、收購和合作夥伴關係等戰略計劃來增加其影響力。

Becton、Dickinson and Company、Medline Industries、ConvaTec Inc.、Potrero Medical、Spiegelberg GmbH 和 Stryker 等公司佔有相當大的市場份額。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章研究方法論

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動力
    • 腹內高壓 (IAH) 和腹腔間隔室綜合徵 (ACS) 的患病率上升
    • 技術進步
  • 市場製約因素
    • IPMD 在普通外科手術中的使用減少和假陰性結果
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 消耗品
    • 設備
  • 按類型
    • 肌肉
    • 腹部
  • 最終用戶
    • 醫院
    • 創傷中心
    • 其他最終用戶
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 法國
      • 德國
      • 英國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 世界其他地區

第6章競爭格局

  • 公司簡介
    • Becton, Dickinson and Company
    • Biometrix Ltd
    • Medline Industries
    • ConvaTec Inc.
    • Holtech Medical
    • Potrero Medical
    • Spiegelberg GmbH
    • Stryker Corp.
    • C2DX, Inc.

第7章 市場機會與今後動向

簡介目錄
Product Code: 68895

The intra-abdominal pressure measurement devices market is anticipated to register a CAGR of about 8.6% during the forecast period.

Key Highlights

  • COVID-19 significantly impacted the abdominal pressure measurement devices market during the initial phases since the import, export, and approvals of medical devices were restricted or delayed due to the pandemic. However, since the restrictions were lifted, the sector bounced back well. Over the last two years, increased intra-abdominal pressure (IAP) measurement devices, new product launches, and a high abdominal compartment syndrome prevalence have contributed to the market recovery.
  • Certain factors driving the market's growth include the increasing prevalence of intra-abdominal hypertension (IAH), abdominal compartment syndrome (ACS), and technological advancements. According to the Health Resources and Services Administration (HRSA) 2021 report, the number of people who had undergone kidney transplantation in 2021 in the United States was 24,670. In addition, there were 90,483 persons on the kidney transplant waiting list.
  • According to an article published in February 2022 in PubMed, elevated IAP was highly prevalent after kidney transplantation and was independently associated with delayed graft function, postoperative complications, and absence of renal function recovery. IAP measurement needs bladder catheterization, which is a simple, standardized method.
  • Since patients who have undergone kidney transplantation need monitoring of IAP to detect further complications and considering the number of kidney transplantations, the demand for IAP measurement devices is likely to rise, thereby boosting the market growth.
  • According to a January 2022 publication in Critical Care Medicine, ACS was detected more frequently in trauma centers (TC) than in non-trauma centers (NTC). As per the same source, ACS is more likely secondary to fluid overload in non-NTC, while it is anticipated to be secondary to shock in TC. Furthermore, increased research activities relating to IAH and ACS will likely promote the market during the forecast period since these will likely increase demand for IAP devices.
  • According to an article published in September 2022 in the Multidisciplinary Digital Publishing Institute (MDPI) Journal, IAH is associated with a poor prognosis and an increased need for surgical interventions with associated morbidity and mortality. In addition, trauma patients with ACS have more complications, mechanical ventilation, organ failure, and extended stay. IAH and ACS develop in the presence of tense abdominal distension. The rise in IAP causes tissue hypoperfusion which can lead to multiple organ dysfunction syndromes and impair the function of nearly every organ system.
  • IAP monitoring has proven to significantly improve patient survival among patients in the Intensive Care Unit with IAH and/or ACS. Hence considering the importance of IAP monitoring, the intra-abdominal pressure measurement devices market will likely witness growth over the forecast period. Given the rising prevalence of IAP hypertension and the importance of IAP monitoring, the intra-abdominal pressure measurement devices market will likely witness growth over the forecast period. However, less utilization of IPMDs in general surgery and false negative results will likely restrain the market growth over the forecast period.

Intra-Abdominal Pressure Measurement Devices Market Trends

Hospital Segment is Anticipated to Hold a Significant Share in the Global Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

  • Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market over the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well as severe organ failure and a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth over the forecast period.
  • As the number of hospitals increases, the demand for IAH devices increases, thereby driving the overall market growth over the forecast period. Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth over the forecast period.
  • For instance, according to the AHA hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Hence, as the number of hospital admissions increases, ICU units are likely to be in demand for IAP measurement devices, which is anticipated to boost market growth during the forecast period.
  • Factors such as technological advancements and prolonged hospital stays are anticipated to promote the market during the forecast period. For instance, according to an article published in April 2022 in PubMed, IAH is a significant and independent predictor of short- and long-term mortality, as well can cause organ failure and lead to a prolonged hospital stay. Furthermore, as per an article published in May 2021 in Sage Journal, IAH is associated with acute renal outcomes in ICU and non-ICU patients. Hence, hospital systems typically use IAH measurement devices on patients undergoing surgery or therapy for chronic conditions to provide better care for their patients. As a result, this can boost the IAP measurement device segment growth during the forecast period.
  • As the number of hospitals increases, the demand for IAH measurement devices increases, thereby driving the overall market growth during the forecast period. Furthermore, according to the American Hospital Association (AHA) hospital statistics for 2022, the United States has 6,093 hospitals, and the total number of admissions to all US hospitals is projected to be 33,356,853 in 2022. Therefore, as hospital admissions rise, ICU units are likely to need IAP measurement devices, which is expected to fuel market growth for IAP measurement devices during the the forecast period.
  • Furthermore, according to the 2022 report from the American Cancer Society (ACS), kidney cancer is among the ten most common cancers in both men and women. The same source estimated that in 2022 there would likely be 28,710 cases of kidney cancer in women and 50,290 cases in men. Overall, the lifetime risk for developing kidney cancer in men is about 1 in 46 (2.02%). The lifetime risk for women is about 1 in 80 (1.03%). Therefore, IAH is more likely to develop in people who have high-risk kidney problems, which is expected to result in hospitalization, hence, accelerating the IAP measurement devices market growth during the forecast period
  • Hence, considering the risk of developing IAP in ICU-admitted patients and the increase in technological advancements in IAP measurement devices, the use of IAP measurement devices in hospitals is likely to increase, thereby boosting the market segment growth during the forecast period.

North America is Expected to Witness a Growth in the Intra-Abdominal Pressure Measurement Devices Market Over the Forecast Period

  • North America is expected to witness growth in the intra-abdominal pressure measurement devices market owing to the rapid rise in the number of hospitals and ambulatory surgical centers, adoption of advanced medical technologies, surge in cases of chronic diseases, and prevalence of intra-abdominal hypertension.
  • Intra-abdominal hypertension (IAH) and abdominal compartment syndrome (ACS) are two complications that intensive care unit (ICU) patients potentially experience. All bodily systems, particularly the cardiovascular, respiratory, renal, and neurological systems, are impacted by ACS and IAH. Hence, the rise in chronic diseases in the North American region can create demand for the IAP devices market. For instance, according to the International Agency for Research on Cancer (IARC) estimations, the number of people affected with Kidney cancer is anticipated to be 10,030 by 2040 in Canada.
  • Digital IAP monitoring devices are now commonly used in the ICU to continuously monitor patients who do not require doctors to monitor them. Hence, digitalizing IAP monitoring devices will propel the IAP measurement devices market forward. For instance, a case study published in the OTA journal in June 2022 showed how the MY01 (NXTSENS, Montreal, Canada) is a minimally invasive device that can accurately and continuously measure changes in intra-compartmental pressure.
  • The management of ACS in level 1 trauma facilities and rural places where continuous clinical monitoring is not possible is significantly impacted by preliminary clinical data. Finally, continuous ICP monitoring has the potential to be a valuable tool for both traumatologists and trauma patients. Similarly, the availability and use of innovative instruments such as digital pressure monitors are expected to increase demand for compartment syndrome measurement devices in the near future.
  • As a result of the increase in the number of hospitals and ambulatory surgical centers, the adoption of advanced medical technologies, high prevalence of intra-abdominal hypertension, North America is expected to witness growth in the IAP measurement devices market during the forecast period.

Intra-Abdominal Pressure Measurement Devices Market Competitor Analysis

The IAP measurement devices market is competitive and consists of a few major players. Companies adopt strategic plans such as mergers, acquisitions, and collaboration in order to increase their presence.

Companies, like Becton, Dickinson and Company, Medline Industries, ConvaTec Inc., Potrero Medical, Spiegelberg GmbH, and Stryker, among others, hold a substantial market share in the market.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Intra-Abdominal Hypertension (IAH) and Abdominal Compartment Syndrome (ACS)
    • 4.2.2 Technological Advancements
  • 4.3 Market Restraints
    • 4.3.1 Less Utilization of IPMDs in General Surgery and False Negative Results
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Disposables
    • 5.1.2 Equipment
  • 5.2 By Type
    • 5.2.1 Muscle
    • 5.2.2 Abdomen
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Trauma Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 France
      • 5.4.2.2 Germany
      • 5.4.2.3 United Kingdom
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Rest of the World

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Becton, Dickinson and Company
    • 6.1.2 Biometrix Ltd
    • 6.1.3 Medline Industries
    • 6.1.4 ConvaTec Inc.
    • 6.1.5 Holtech Medical
    • 6.1.6 Potrero Medical
    • 6.1.7 Spiegelberg GmbH
    • 6.1.8 Stryker Corp.
    • 6.1.9 C2DX, Inc.

7 MARKET OPPORTUNITIES AND FUTURE TRENDS